Kaletra Oral Solution 80-20Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Kaletra: Oral solution (80-20mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

LOPINAVIR; RITONAVIR (loe PIN a veer; ri TOE na veer) is two antiretroviral medicines in one tablet. It is used with other medicines to treat HIV. This medicine is not a cure for HIV. It will not stop the spread of HIV to others.

In-Depth Information

Kaletra 80mg-20mg/ml Solution

NDC: 000743956
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Human Immunodeficiency Virus (HIV) Infection

Sometimes used for but not FDA approved for the following conditions:
Human Immunodeficiency Virus (HIV) Prophylaxis

Storage Information
Refrigerate (between 36 and 46 degrees F)
Product is stable until the expiration date on the label if refrigerated (36 to 46 degrees F)
May be stored at temperatures up to 77 degrees F if used within 2 months
Avoid excessive heat (above 104 degrees F)
Kaletra 80mg-20mg/ml Solution

Reported Side Effects for Kaletra 80mg-20mg/ml Solution

High Uric Acid Level Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Low Phosphate Level Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Inflamed Blood Vessels Incidence:
0.1%*
Severity: SEVERE
Onset: DELAYED
Dead Bone Incidence:
0.1%*
Severity: SEVERE
Onset: DELAYED
Cholangitis Incidence:
0.1%*
Severity: MODERATE
Onset: DELAYED
Heart Block Incidence:
0.1%*
Severity: SEVERE
Onset: EARLY
Fatty Change Incidence:
0.1%*
Severity: MODERATE
Onset: DELAYED
Enlarged Liver Incidence:
0.2%*
Severity: MODERATE
Onset: DELAYED
Ringing In Ears Incidence:
0.2%*
Severity: MILD
Onset: DELAYED
Stomach Ulcer Incidence:
0.2%*
Severity: SEVERE
Onset: DELAYED
Fecal Incontinence Incidence:
0.2%*
Severity: MODERATE
Onset: EARLY
Causing To Be Hungry Incidence:
0.2%*
Severity: MILD
Onset: DELAYED
Balance Problems Incidence:
0.3%*
Severity: MILD
Onset: EARLY
Shaking Incidence:
0.3%*
Severity: MILD
Onset: EARLY
Dry Mouth Incidence:
0.3%*
Severity: MILD
Onset: EARLY
Visual Impairment Incidence:
0.3%*
Severity: SEVERE
Onset: EARLY
Convulsions Incidence:
0.3%*
Severity: SEVERE
Onset: DELAYED
Electrolyte Imbalance Incidence:
0.4%*
Severity: SEVERE
Onset: DELAYED
Heart Attack Incidence:
0.4%*
Severity: SEVERE
Onset: DELAYED
Hair Loss Incidence:
0.4%*
Severity: MILD
Onset: DELAYED
Intestinal Bleeding Incidence:
0.5%*
Severity: SEVERE
Onset: DELAYED
Blood Clot Incidence:
0.7%*
Severity: SEVERE
Onset: DELAYED
Breakdown Of Muscle Incidence:
0.7%*
Severity: SEVERE
Onset: DELAYED
Decreased Sexual Desire Incidence:
0.7%*
Severity: MILD
Onset: DELAYED
Inflamed Stomach Incidence:
0.8%*
Severity: MODERATE
Onset: DELAYED
Weight Gain Incidence:
0.8%*
Severity: MILD
Onset: DELAYED
Blood In The Urine Incidence:
0.8%*
Severity: MODERATE
Onset: DELAYED
Gonadal Suppression Incidence:
0.8%*
Severity: MILD
Onset: DELAYED
Mouth Sores Incidence:
0.9%*
Severity: MODERATE
Onset: DELAYED
Mouth Ulcers Incidence:
0.9%*
Severity: MODERATE
Onset: DELAYED
High Bilirubin Level Incidence:
1.0-3.0%*
Severity: MODERATE
Onset: DELAYED
Low White Blood Cells Incidence:
1.0-5.0%*
Severity: MODERATE
Onset: DELAYED
Increased Blood Sugar Incidence:
1.0-5.0%*
Severity: MODERATE
Onset: DELAYED
Constipation Incidence:
1.0%*
Severity: MODERATE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
1.0-11.0%*
Severity: MODERATE
Onset: DELAYED
Itching Incidence:
1.1%*
Severity: MILD
Onset: RAPID
Diabetes Incidence:
1.1%*
Severity: MODERATE
Onset: DELAYED
Kidney Failure Incidence:
1.2%*
Severity: SEVERE
Onset: DELAYED
Weakness Incidence:
1.3%*
Severity: MILD
Onset: EARLY
Enlarged Lymph Nodes Incidence:
1.3%*
Severity: MODERATE
Onset: DELAYED
Gas Incidence:
1.4%*
Severity: MILD
Onset: EARLY
Hemorrhoids Incidence:
1.5%*
Severity: MODERATE
Onset: DELAYED
Heartburn Incidence:
1.5%*
Severity: MILD
Onset: DELAYED
Night Sweats Incidence:
1.6%*
Severity: MILD
Onset: EARLY
Inflamed Pancreas Incidence:
1.7%*
Severity: SEVERE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
1.7%*
Severity: MODERATE
Onset: DELAYED
Heavy Menstrual Period Incidence:
1.7%*
Severity: MILD
Onset: DELAYED
No Menstrual Periods Incidence:
1.7%*
Severity: MILD
Onset: DELAYED
Lightheadedness Incidence:
1.7%*
Severity: MILD
Onset: EARLY
Impotence (erectile Dysfunction) Incidence:
1.7%*
Severity: MODERATE
Onset: DELAYED
High Blood Pressure Incidence:
1.8%*
Severity: MODERATE
Onset: EARLY
Muscle Pain Incidence:
1.8%*
Severity: MILD
Onset: EARLY
Dandruff Incidence:
1.9%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Decreased Appetite Incidence:
2.0%*
Severity: MILD
Onset: DELAYED
Nerve Pain Incidence:
2.0%*
Severity: MODERATE
Onset: DELAYED
Anemia Incidence:
2.1%*
Severity: MODERATE
Onset: DELAYED
Fat Redistribution Incidence:
2.2%*
Severity: MODERATE
Onset: DELAYED
Weight Loss Incidence:
2.3%*
Severity: MILD
Onset: DELAYED
Inflamed Colon Incidence:
2.5%*
Severity: MODERATE
Onset: DELAYED
Low Blood Sodium Levels Incidence:
3.0%*
Severity: MODERATE
Onset: DELAYED
High Triglycerides Incidence:
3.0-36.0%*
Severity: MODERATE
Onset: DELAYED
High Amylase Levels Incidence:
3.0-8.0%*
Severity: MODERATE
Onset: DELAYED
Increased Blood Fats Incidence:
3.0-39.0%*
Severity: MODERATE
Onset: DELAYED
High Cholesterol Incidence:
3.0-39.0%*
Severity: MODERATE
Onset: DELAYED
High Sodium Levels Incidence:
3.0%*
Severity: MODERATE
Onset: DELAYED
Infection Incidence:
3.3-13.9%*
Severity: MILD
Onset: DELAYED
Liver Infection Incidence:
3.5%*
Severity: MODERATE
Onset: DELAYED
Skin Rash Incidence:
3.8-12.0%*
Severity: MILD
Onset: EARLY
Inability To Sleep Incidence:
3.8%*
Severity: MILD
Onset: EARLY
Nervousness Incidence:
3.9%*
Severity: MILD
Onset: DELAYED
Low Platelet Count Incidence:
4.0%*
Severity: MODERATE
Onset: DELAYED
Headache Incidence:
6.3%*
Severity: MILD
Onset: EARLY
Back Pain Incidence:
6.4%*
Severity: MILD
Onset: DELAYED
Joint Pain Incidence:
6.4%*
Severity: MILD
Onset: DELAYED
Vomiting Incidence:
6.8-21.0%*
Severity: MILD
Onset: EARLY
Weakness Incidence:
7.6%*
Severity: MILD
Onset: DELAYED
Tired Incidence:
7.6%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
10.3%*
Severity: MILD
Onset: EARLY
Metallic Taste Incidence:
22.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Kaletra 80mg-20mg/ml Solution

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Major Lifestyle Interaction
Alcohol and Kaletra 80mg-20mg/ml Solution(Ritonavir)
Alcohol and Ritonavir(Ritonavir)
Although an interaction is possible, these drugs may be used together with caution. If these drugs are taken together, the effectiveness of your ritonavir medication may be decreased. If you notice your medicines are not working as well for you or any unusual side effects, notify your health care provider immediately. You will be closely monitored.
Moderate Lifestyle Interaction
Marijuana and Kaletra 80mg-20mg/ml Solution(Lopinavir)
Marijuana and Protease inhibitors(Lopinavir)
Although an interaction is possible, these drugs may be used together. In therory, side effects from Marijuana, Medical may get worse if you take Anti-retroviral protease inhibitors. However, the importance of this interaction is not known. Notify your health care provider if you notice increased fatigue, nausea, vomiting, or any other unusual effects.
Moderate Lifestyle Interaction
Grapefruit juice and Kaletra 80mg-20mg/ml Solution(Ritonavir)
Grapefruit juice and Ritonavir(Ritonavir)
Although an interaction is possible, these drugs may be given with grapefruit juice. If given with grapefruit juice, you may experience more side effects. If you notice any new or unusual side effects, notify your health care provider immediately. You will be closely monitored.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Kaletra

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5